Cargando…
The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma
BACKGROUND: The incidence of melanoma is increasing and 37% of patients with metastatic melanoma eventually have brain metastasis (BM). Currently, there is no consensus on screening for BM in patients with resected stage III melanoma. However, given the high incidence of BM, routine screening magnet...
Autores principales: | Derks, S.H.A.E., de Joode, K., Mulder, E.E.A.P., Ho, L.S., Joosse, A., de Jonge, M.J.A., Verhoef, C., Grünhagen, D.J., Smits, M., van den Bent, M.J., van der Veldt, A.A.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808474/ https://www.ncbi.nlm.nih.gov/pubmed/36265261 http://dx.doi.org/10.1016/j.esmoop.2022.100600 |
Ejemplares similares
-
Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation
por: Mulder, E.E.A.P., et al.
Publicado: (2021) -
Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma
por: Mulder, E.E.A.P., et al.
Publicado: (2020) -
Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study
por: Verver, D, et al.
Publicado: (2019) -
Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma
por: Kamminga, Nadia C.W., et al.
Publicado: (2022) -
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data
por: Derks, Sophie H. A. E., et al.
Publicado: (2023)